SCHEMBL6204986

SCHEMBL6204986

C#C[C@H](C)O/N=C1/c2cc(OC)c(OC)cc2-c2[nH]c3ccc(OCCN(C)C)cc3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 5/20 0.42
PARP1 P09874 1/20 0.35
TLR8 Q9NR97 3/20 0.34
TLR7 Q9NYK1 3/20 0.34
TLR9 Q9NR96 2/20 0.34
HTR6 P50406 4/20 0.34
HTR1A P08908 3/20 0.34
HTR1D P28221 3/20 0.34
HTR7 P34969 3/20 0.34
HTR5A P47898 3/20 0.34
SLC6A4 P31645 1/20 0.34
FLT3 P36888 1/20 0.34
HTR1E P28566 2/20 0.33
SLC6A2 P23975 1/20 0.33
TOP2A P11388 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MAOA P21397 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204992 1.00 TOP1 (0.42) TOP1PARP1TLR8TLR7TLR9
SCHEMBL6203836 1.00 TOP1 (0.42) TOP1PARP1TLR8TLR7TLR9
SCHEMBL6203839 1.00 TOP1 (0.42) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7235161 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7236487 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7235167 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7227269 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7236489 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
Hydrochloric Acid SCHEMBL7227273 0.99 TOP1 (0.41) TOP1PARP1TLR8TLR7TLR9
SCHEMBL7234640 0.94 TOP1 (0.40) TOP1PARP1TLR8TLR7TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266887-B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-08-17 EP claimed
US-6627650-B2 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents. LES LABORATOIRES SERVIER (FR) 2003-09-30 US claimed
US-20030125369-A1 Indeno(1,2-b)indole oximes or indeno(1,2-b) indole hydrazones used as anticancer agent LES LABORATOIRES SERVIER (FR) 2003-07-03 US claimed
US-6627650-B2 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents. LES LABORATOIRES SERVIER (FR) 2003-09-30 US disclosed
US-20030125369-A1 Indeno(1,2-b)indole oximes or indeno(1,2-b) indole hydrazones used as anticancer agent LES LABORATOIRES SERVIER (FR) 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125369-A1 Indeno(1,2-b)indole oximes or indeno(1,2-b) indole hydrazones used as anticancer agent IDO1, IDO2, AHR TOP1 104/4885PARP1 265/4885TLR8 1794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.